GSK extends Nicorette line
This article was originally published in The Tan Sheet
Executive SummaryGlaxoSmithKline launches Nicorette Mini Lozenges in discreet, pocket-size vials to help smokers address cravings and withdrawal symptoms as they try to quit. The firm said April 27 the line extension dissolves up to three times faster than other nicotine replacement lozenges "and can double a smoker's chances of successfully quitting versus placebo." GSK also announced a "Mini Moments" contest on Facebook allowing consumers to share reasons for quitting. The mint lozenges come in 2-mg and 4-mg sizes. A package of 81 retails for a suggested $55.49
You may also be interested in...
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.